Lexaria Bioscience Corp.
NASDAQ: LEXX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard C. Christopher
- Employees
- 7
- Headquarters
- Kelowna, Canada
- IPO year
- 2021
- Market cap
- $11.2M
- Website
- https://www.lexariabioscience.com
Loading LEXX…
Loading profile data…Frequently asked questions about LEXX
What does Lexaria Bioscience Corp. (LEXX) do?
Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of active pharmaceutical ingredients, enhancing their absorption into the bloodstream. This innovative platform has shown impressive results, boosting th...
Where does LEXX trade?
Lexaria Bioscience Corp. (LEXX) trades on the NASDAQ Capital Market.
What sector is LEXX in?
Lexaria Bioscience Corp. (LEXX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Lexaria Bioscience Corp.?
Richard C. Christopher is the chief executive officer of Lexaria Bioscience Corp. (LEXX).
Where is Lexaria Bioscience Corp. headquartered?
Lexaria Bioscience Corp. is headquartered in Canada.
Does LEXX pay a dividend?
Lexaria Bioscience Corp. (LEXX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LEXX go public?
Lexaria Bioscience Corp. (LEXX) completed its initial public offering in 2021.